Bacterial Infection Of Skin — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for bacterial infection of skin. 13 active patents protecting 1 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

1
Approved drugs
13
Active US patents
61/100
Avg vulnerability
Annual revenue covered

Originators in Bacterial Infection Of Skin

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Paratek Pharms 13 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating bacterial infection of skin. Each bar = one year. Y-axis scaled to peak year (5 patents).

5
29
2
30
1
31
5
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Nuzyra
OMADACYCLINE TOSYLATE
Paratek Pharms 13 61 2029-03-05

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
10124014 Nuzyra method of use 75 2029-03-05
9724358 Nuzyra method of use 75 2029-03-05
10124014 Nuzyra method of use 75 2029-03-05
9724358 Nuzyra method of use 75 2029-03-05
9265740 Nuzyra method of use 68 2030-10-24
10111890 Nuzyra method of use 62 2037-08-03
10383884 Nuzyra method of use 62 2037-10-31
10835542 Nuzyra method of use 62 2037-10-31
10383884 Nuzyra method of use 62 2037-10-31
10835542 Nuzyra method of use 62 2037-10-31

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8383610 Nuzyra composition of matter 10 2030-09-23
9314475 Nuzyra formulation 48 2031-03-18
9265740 Nuzyra formulation 55 2029-03-05
10383884 Nuzyra method of use 62 2037-10-31
10835542 Nuzyra method of use 62 2037-10-31
10835542 Nuzyra method of use 62 2037-10-31
10383884 Nuzyra method of use 62 2037-10-31
10111890 Nuzyra method of use 62 2037-08-03
9265740 Nuzyra method of use 68 2030-10-24
9724358 Nuzyra method of use 75 2029-03-05

Related